Primerica PRI Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Rhythm Pharmaceuticals, Inc.RYTM

-$544K-5,340%

Jackson FinancialJXN

-$552M-191%

Ford Motor CompanyF

-$69M-203%

Construction PartnersROAD

-$158K-168%

ArganAGX

-$2.66M-199%

CytokineticsCYTK

-$1.84M-240%

Other financials

Income statement

See full

Revenue$872.7M+8.4%

Gross profit$775.2M+17.3%

Net income$190.1M+12.4%

EPS (diluted)$5.97+18.2%

Balance sheet

See full

Cash & equivalents$645.8M+3.3%

Total debt$48.4M-8.6%

Total equity$2.5B+11.7%

Total assets$14.7B+0.6%

Cash flow

See full

Operating cash flow$156.8M-20.6%

Valuation

See full

Market cap$8.79B-16.2%

Enterprise value$8.19B-17.5%

P/E11.4×-9.5×

P/S2.6×-0.7×

Profitability

See full

Gross margin98.1%+0.2pp

Net margin23%+7.1pp

Returns & leverage

See full

Return on equity32.3%+9.8pp

Debt / equity0×0.0×

Where this comes from

Reported directly by Primerica in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Primerica’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Primerica's unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Primerica's unrealized gains (losses) on available-for-sale securities?: Primerica (PRI) reported unrealized gains (losses) on available-for-sale securities of -$31.73M in Q1 2026.
How has Primerica's unrealized gains (losses) on available-for-sale securities changed year-over-year?: Primerica's unrealized gains (losses) on available-for-sale securities decreased by 209.1% year-over-year, from $29.08M to -$31.73M.